comparemela.com

Latest Breaking News On - Alfred altomari - Page 1 : comparemela.com

Agile Therapeutics, Inc (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call. Please note, today s event is being recorded.

Scott coianteMatt rileyOren livnatAl altomariAlfred altomariAmy welshAgile therapeutics incTwentyeight healthAgile therapeuticsCall transcript novemberAgile therapeutics third quarterResults conferenceChief executive officerChief financialChief commercial officerInvestor relations

EQS-News: Women s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow

EQS-News: Agile Therapeutics, Inc. Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow 15.11.2022 / 14:15 CET/CEST The issuer is solely responsible for the content of this announcement. Agile Thera.

New yorkUnited statesMatt rileyAlfred altomariAmy welshHead of investor relations corporate communicationsCorium incAfaxys incDistribution servicesAgile therapeutics incDare bioscience incNews serviceHologic incAgile therapeuticsResults and corporateFinancial results highlights

EQS-News: Agile Therapeutics, Inc : Women s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow

EQS-News: Agile Therapeutics, Inc. Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow 15.11.2022

New yorkUnited statesMatt rileyAlfred altomariAmy welshHead of investor relations corporate communicationsCorium incAfaxys incDistribution servicesAgile therapeutics incDare bioscience incNews serviceHologic incAgile therapeuticsResults and corporateFinancial results highlights

vimarsana © 2020. All Rights Reserved.